Literature DB >> 16797358

Early changes of small intestine function in rats after liver transplantation.

C Zheyu1, Y Lunan.   

Abstract

OBJECTIVE: The aims of this study were to explore the concomitant changes of the barrier function, bacterial translocation, absorption, and small intestinal motility in rats after liver transplantation and to correlate these changes with levels of plasma endotoxin.
METHODS: Thirty Wistar rats were divided randomly between a sham operation group (n=10) and a liver transplantation group (n=10 pairs). The intestinal transit function, intestinal permeability, bacterial translocation, absorption function, levels of plasma endotoxin, and nitrogen monoxide (NO) changes in plasma and small intestinal mucosa were monitored in the two groups. The expression of iNOS mRNA in the intestine was investigated by reverse transcriptase-polymerase chain reactions.
RESULTS: Significant differences were observed between the liver transplantation group and the sham operation group for aspects of intestinal transit function, intestinal permeability, bacterial translocation, absorption function, and NO changes in both plasma and small intestine. Compared with the sham operation group, the expression of iNOS mRNA was significantly increased (P<.05) in the small intestine of rats that had undergone liver transplantation.
CONCLUSION: The functions of motility, barrier, and absorption in the intestine were decreased among rats that had undergone liver transplantation. Reduced motility in the small intestine of the rats following liver transplantation may be related to the enhanced expression of iNOS in the intestine with a negative correlation to plasma levels of endotoxin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797358     DOI: 10.1016/j.transproceed.2006.03.019

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.

Authors:  Kelong Han; Robert Bies; Heather Johnson; Blair Capitano; Raman Venkataramanan
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

2.  Expression and function of intestinal hexose transporters after small intestinal denervation.

Authors:  Corey W Iqbal; Javairiah Fatima; Judith Duenes; Scott G Houghton; Michael S Kasparek; Michael G Sarr
Journal:  Surgery       Date:  2009-05-08       Impact factor: 3.982

3.  Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.

Authors:  Kelong Han; B Capitano; R Bies; B A Potoski; S Husain; S Gilbert; D L Paterson; K McCurry; R Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

Review 4.  Global consequences of liver ischemia/reperfusion injury.

Authors:  Constantinos Nastos; Konstantinos Kalimeris; Nikolaos Papoutsidakis; Marios-Konstantinos Tasoulis; Panagis M Lykoudis; Kassiani Theodoraki; Despoina Nastou; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Oxid Med Cell Longev       Date:  2014-04-01       Impact factor: 6.543

5.  Intestinal NF-E2-related factor-2 expression and antioxidant activity changes in rats undergoing orthotopic liver autotransplantation.

Authors:  Mian Ge; Xinjin Chi; Ailan Zhang; Gangjian Luo; Guoliang Sun; Hanbin Xie; Ziqing Hei
Journal:  Oncol Lett       Date:  2013-09-12       Impact factor: 2.967

6.  Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver Transplantation.

Authors:  Wei Song; Li-Ying Sun; Zhi-Jun Zhu; Lin Wei; Wei Qu; Zhi-Gui Zeng; Yun-Sheng Yang
Journal:  Front Physiol       Date:  2021-06-29       Impact factor: 4.566

7.  Intestinal injury following liver transplantation was mediated by TLR4/NF-κB activation-induced cell apoptosis.

Authors:  Dong-Dong Yuan; Xin-Jin Chi; Yi Jin; Xi Li; Mian Ge; Wan-Ling Gao; Jian-Qiang Guan; Ai-Lan Zhang; Zi-Qing Hei
Journal:  Mol Med Rep       Date:  2015-12-24       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.